Orphan Drug Development

ASHBURN, Va., June 16, 2026 Quoin Pharmaceuticals announced a positive clinical update from its ongoing pediatric Netherton Syndrome (NS)...

AUSTIN, Texas, Feb. 12, 2026 — IntraBio announced positive topline results from its pivotal Phase III IB1001-303 clinical trial...